| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | 4 | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2027 | ‡‡‡‡ |
|
| 2026 | ‡‡‡‡ |
|
| 2025 | 0.11 |
—
|
| 2024 | 0.14 |
—
—
—
—
|
| 2023 | 0.04 |
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 36.05 | 31.01 | 29.75 | 57.66 |
| Receivables | 392.92 | 177.27 | 162.30 | 142.95 |
| Inventory | 174.72 | 164.91 | 179.02 | 158.90 |
| Other | 416.28 | 440.08 | 478.97 | 472.13 |
| 1,019.97 | 813.27 | 850.03 | 831.65 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 134.50 | 163.05 | 158.36 | 128.77 |
| ST’ Debt | 53.91 | 31.35 | 35.23 | 35.50 |
| Other | 171.00 | — | — | — |
| 395.53 | 456.10 | 408.96 | 383.97 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡ | ‡‡‡ |
| Book Value | — | ‡‡‡ | ‡‡‡‡‡ |
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 663.39 | 659.44 | 661.66 | — |
—
|
| ’25 | 683.78 | 665.25 | 673.80 | 712.01 |
2,734.84
|
| ’24 | 717.92 | 705.37 | 698.25 | 684.28 |
2,805.82
|
| ’23 | 700.70 | 699.31 | 709.38 | 715.90 |
2,825.29
|
| ’22 | — | — | — | 683.17 |
2,687.01
|
| ’21 | — | — | — | — |
2,456.58
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 37.69 | 58.25 | 64.94 | — |
—
|
| ’25 | 3.78 | 6.66 | 22.86 | 30.93 |
64.23
|
| ’24 | 51.51 | 76.04 | 48.66 | 295.59 |
471.79
|
| ’23 | 7.97 | 60.79 | 75.17 | 113.04 |
256.98
|
| ’22 | — | — | — | 232.85 |
232.85
|
| ’21 | — | — | — | 244.34 |
244.34
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 28.57 | 52.11 | 47.25 | — |
—
|
| ’25 | (10.61) | (2.00) | 8.17 | 15.73 |
11.29
|
| ’24 | 34.56 | 63.16 | 27.70 | 272.74 |
398.15
|
| ’23 | (5.68) | 52.75 | 55.19 | 88.02 |
190.29
|
| ’22 | — | — | — | 163.71 |
163.71
|
| ’21 | — | — | — | 156.90 |
156.90
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | (0.05) | 0.02 | 0.08 | — |
—
|
| ’25 | 0.01 | (0.21) | (0.01) | (0.10) |
(0.31)
|
| ’24 | 0.09 | 0.05 | 0.04 | (0.02) |
0.16
|
| ’23 | — | — | — | 0.71 |
1.62
|
| ’22 | — | — | — | 0.18 |
1.09
|
| ’21 | — | — | — | — |
0.57
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 13.83 | 8.92 | 3.98 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | 21.44 | 22.37 | 16.68 | — | — | — |
High Price
|
| — | — | — | — | — | — | — | 10,500 | 10,800 | 18,150 | — | — | — |
Employees
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | 0.00 | 0.27 | 0.26 | 0.15 | — | — | — |
Revenue/Emp
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,687.01 | 2,825.29 | 2,805.82 | 2,734.84 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.93% | 30.26% | 29.08% | 26.50% | — | — | — |
Gross Margin
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 189.96 | 269.73 | 32.03 | (44.31) | ‡‡‡‡‡ | — | — |
EBT
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.07% | 9.55% | 1.14% | (1.62%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 141.68 | 213.16 | 20.97 | (40.22) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 134.35 | 136.50 | 145.46 | 146.65 | — | — | — |
Depreciation
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.55 | 21.61 | 21.34 | 20.76 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| — | — | — | — | ‡‡‡‡ | ‡‡‡‡ | 1.09 | 1.63 | 0.16 | (0.31) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.78 | 1.97 | 3.59 | 0.49 | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.53) | (0.51) | (0.56) | (0.40) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.25 | 1.46 | 3.03 | 0.09 | — | — | — |
Free CF/Sh
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | 17.87 | 6.71 | 6.87 | 6.57 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 130.73 | 130.73 | 131.51 | 131.75 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.38 | 18.38 | 93.13 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.90 | 0.79 | 0.70 | 0.22 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.08 | 2.53 | 2.17 | 0.69 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.93 | 1.35 | 1.15 | 0.69 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.78 | 20.02 | 8.09 | 167.23 | — | — | — |
EV/FCF
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 232.85 | 256.98 | 471.79 | 64.23 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | (69.13) | (66.69) | (73.64) | (52.94) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| — | — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 163.71 | 190.29 | 398.15 | 11.29 | ‡‡‡‡‡ | — | — |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 585.09 | 624.44 | 357.17 | 441.07 | — | — | — |
Working Cap'
|
| — | — | — | — | — | ‡‡‡‡‡ | 107.27 | 1,621.82 | 1,294.41 | 1,321.45 | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | 83.53 | 1,585.77 | 1,263.40 | 1,291.70 | — | — | — |
Net Debt
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | 2,335.81 | 877.36 | 903.05 | 865.64 | — | — | — |
Sh' Equity
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | 4.54% | 6.78% | 0.69% | (1.38%) | ‡‡‡‡‡ | — | — |
ROA
|
| — | — | — | — | ‡‡‡ | ‡‡‡‡‡ | 4.97% | 5.53% | 4.56% | 1.87% | — | — | — |
ROIC
|
| — | — | — | — | ‡‡‡ | ‡‡‡ | 6.07% | 13.27% | 2.36% | (4.55%) | ‡‡‡‡‡ | — | — |
ROE
|
Vestis Corporation (VSTS), spun off from Aramark in 2023 as a pure-play uniform rental leader, has grappled with inflation, supply chain woes, and sector slowdowns, driving its stock down 81% from 2024 highs to near $4 lows in 2025. Yet revenue has shown remarkable stability—hovering at $2.7-2.8 billion with a modest 3.2% CAGR over five years—bolstered by recurring contracts akin to resilient peers like Cintas during past recessions. Recent dips (2.6% in 2025) are projected to trough in 2026 before a V-shaped rebound to 4% growth by 2028, though red flags like plunging revenue per employee (down 42%) and gross margins (to 26.5%) signal efficiency strains from a 68% headcount surge.
Profitability swung wildly post-spin-off—from 9.6% EBT margins in 2023 to losses in 2025—but operating cash flow resilience peaked at $472 million in 2024, yielding strong FCF per share. Insider confidence screams bullish: $19.7 million in buys (no sells), including CEO and major holder purchases at depressed prices, echoing pre-rally signals in spin-offs like GE HealthCare. Valuations now scream value—0.22x PS, 0.69x PB, and EV/Sales at 0.69x—deeply discounted versus peers at 1.5-2x sales, with forecasts eyeing EPS recovery to $0.32 by 2027.
Analysts project a profitability pivot with 11.2% ROE rebound and mid-teens EPS growth, potentially mirroring Cintas’s post-downturn surge for 20-30% upside over 18-24 months. Risks loom from margin drag, debt, and cyclical hospitality exposure (30% of routes), but stable fundamentals and insider alignment position Vestis at a compelling crossroads for patient investors.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.